NO872729L - Cefalosporinhydrat og fremgangsmŸte for dets fremstilling. - Google Patents

Cefalosporinhydrat og fremgangsmŸte for dets fremstilling.

Info

Publication number
NO872729L
NO872729L NO872729A NO872729A NO872729L NO 872729 L NO872729 L NO 872729L NO 872729 A NO872729 A NO 872729A NO 872729 A NO872729 A NO 872729A NO 872729 L NO872729 L NO 872729L
Authority
NO
Norway
Prior art keywords
cephalosporine
hydrate
procedure
preparation
cephalosporine hydrate
Prior art date
Application number
NO872729A
Other languages
English (en)
Other versions
NO170889B (no
NO872729D0 (no
NO170889C (no
Inventor
Yoshio Hamashima
Kyoji Minami
Kyozo Kawata
Teruo Sakamoto
Toyohiko Takeda
Yusuke Suzuki
Masanori Tujikawa
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61156954A external-priority patent/JP2544113B2/ja
Priority claimed from JP21626086A external-priority patent/JPH0717651B2/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO872729D0 publication Critical patent/NO872729D0/no
Publication of NO872729L publication Critical patent/NO872729L/no
Priority to NO911964A priority Critical patent/NO303264B1/no
Priority to NO921401A priority patent/NO921401D0/no
Publication of NO170889B publication Critical patent/NO170889B/no
Publication of NO170889C publication Critical patent/NO170889C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
NO872729A 1986-07-02 1987-06-30 Fremgangsmaate for fremstilling av et stabilt krystallinskdi- eller trihydrat av 7beta-((z)-2-(2-aminotiazol-4-yl)-4-karboksybut-2-enoylamino)-3-cefem-4-karboksylsyre NO170889C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO911964A NO303264B1 (no) 1986-07-02 1991-05-22 FremgangsmÕte for fremstilling av et stabilt kapselpreparat
NO921401A NO921401D0 (no) 1986-07-02 1992-04-09 Fremgansmaate for fremstilling av et stabilt kapselpreparat

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61156954A JP2544113B2 (ja) 1986-07-02 1986-07-02 安定なカプセル製剤
JP21626086A JPH0717651B2 (ja) 1986-09-12 1986-09-12 経口投与用セフアロスポリン水和物結晶

Publications (4)

Publication Number Publication Date
NO872729D0 NO872729D0 (no) 1987-06-30
NO872729L true NO872729L (no) 1988-01-04
NO170889B NO170889B (no) 1992-09-14
NO170889C NO170889C (no) 1992-12-23

Family

ID=26484565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872729A NO170889C (no) 1986-07-02 1987-06-30 Fremgangsmaate for fremstilling av et stabilt krystallinskdi- eller trihydrat av 7beta-((z)-2-(2-aminotiazol-4-yl)-4-karboksybut-2-enoylamino)-3-cefem-4-karboksylsyre

Country Status (27)

Country Link
US (2) US4812561A (no)
KR (1) KR950005302B1 (no)
CN (1) CN1015106B (no)
AR (1) AR243893A1 (no)
AT (1) AT392472B (no)
AU (1) AU594167B2 (no)
BE (1) BE1001691A4 (no)
CA (1) CA1283405C (no)
CH (1) CH672788A5 (no)
DE (1) DE3721913A1 (no)
DK (1) DK161080C (no)
ES (2) ES2004952A6 (no)
FI (1) FI89052C (no)
FR (1) FR2601014B1 (no)
GB (1) GB2192183B (no)
GR (1) GR871014B (no)
HK (1) HK47893A (no)
HU (1) HU200777B (no)
IE (1) IE59613B1 (no)
IL (1) IL83059A (no)
IT (1) IT1211469B (no)
NL (1) NL193136C (no)
NO (1) NO170889C (no)
NZ (1) NZ220764A (no)
PL (1) PL159180B1 (no)
RU (1) RU1829932C (no)
SE (1) SE466257B (no)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
PL171630B1 (pl) * 1992-04-30 1997-05-30 Schering Corp Preparat hydratowanego ceftibutenu i sposób wytwarzania preparatu hydratowanego ceftibutenu PL PL PL PL PL PL PL PL PL
EP2277922A1 (en) * 1998-10-27 2011-01-26 Westlake Longview Corporation Process for the polymerization of olefins; polyethylenes, and films and articles produced therefrom
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
CA2533292C (en) * 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2533178C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258944B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1653925A1 (en) * 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005023184A2 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2538064C (en) * 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004308419B2 (en) * 2003-12-24 2011-06-02 Victory Pharma, Inc. Enhanced absorption of modified release dosage forms
EP1771158A4 (en) * 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp TABLET FOR PULSED DELIVERY
US20110104109A1 (en) * 2005-07-13 2011-05-05 Frank Bennett Tetracyclic indole derivatives and their use for treating or preventing viral infections
EP3173084B1 (en) 2005-11-11 2019-10-23 Boehringer Ingelheim International GmbH Quinazoline derivatives for the treatment of cancer diseases
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
CN101611025A (zh) 2006-12-22 2009-12-23 先灵公司 5,6-环化的吲哚衍生物及其使用方法
BRPI0720625A2 (pt) 2006-12-22 2014-03-25 Schering Corp Derivados de indol de 4,5-anel anulados e métodos de uso dos mesmos
CA2673254C (en) * 2006-12-22 2013-09-10 Schering Corporation 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
TW200911807A (en) * 2007-08-29 2009-03-16 Schering Corp 2,3-substituted azaindole derivatives and methods of use thereof
JP5272008B2 (ja) * 2007-08-29 2013-08-28 メルク・シャープ・アンド・ドーム・コーポレーション 置換インドール誘導体およびその使用の方法
JP5272007B2 (ja) * 2007-08-29 2013-08-28 メルク・シャープ・アンド・ドーム・コーポレーション ウイルス感染症を治療するための２，３−置換インドール誘導体
WO2009064848A1 (en) * 2007-11-16 2009-05-22 Schering Corporation 3-heterocyclic substituted indole derivatives and methods of use thereof
MX2010005355A (es) * 2007-11-16 2010-06-02 Schering Corp Derivados de indol sustituidos con 3-aminosulfonilo y metodos de uso de los mismos.
EP2303893B1 (en) * 2008-06-13 2016-12-07 Merck Sharp & Dohme Corp. Tricyclic indole derivatives
US8470834B2 (en) 2008-08-20 2013-06-25 Merck Sharp & Dohme Corp. AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
WO2010022121A1 (en) 2008-08-20 2010-02-25 Schering Corporation Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2326626B1 (en) 2008-08-20 2013-10-16 Merck Sharp & Dohme Corp. Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
JP5674661B2 (ja) 2008-08-20 2015-02-25 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． エチニル置換ピリジンおよびピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
EP2435424B1 (en) 2009-05-29 2015-01-21 Merck Sharp & Dohme Corp. Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
EP2451445B1 (en) 2009-07-06 2019-04-03 Boehringer Ingelheim International GmbH Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
US20120276047A1 (en) 2009-11-25 2012-11-01 Rosenblum Stuart B Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
CA2785488A1 (en) 2009-12-22 2011-07-21 Merck Sharp & Dohme Corp. Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
WO2011103441A1 (en) 2010-02-18 2011-08-25 Schering Corporation Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
BR112012022125A2 (pt) 2010-03-09 2016-11-01 Merck Sharp & Dhme Corp composto, sal de dicloridrato, composição farmacêutica, uso do composto, e, método para tratar um paciente
WO2011139253A2 (en) 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical compositions comprising ceftibuten
AU2011286276A1 (en) 2010-07-26 2013-01-24 Merck Sharp & Dohme Corp. Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
WO2012050848A1 (en) 2010-09-29 2012-04-19 Schering Corporation Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
EP2697242B1 (en) 2011-04-13 2018-10-03 Merck Sharp & Dohme Corp. 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
BR112013026345A2 (pt) 2011-04-13 2019-04-24 Merck Sharp & Dohe Corp. composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
WO2013033901A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
WO2013033900A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
WO2013033899A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
WO2013039876A1 (en) 2011-09-14 2013-03-21 Merck Sharp & Dohme Corp. Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
EP2833874A1 (en) * 2012-04-04 2015-02-11 Mahmut Bilgic Capsule formulations comprising ceftibuten
EP2815743A1 (en) 2013-06-21 2014-12-24 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten formulations
WO2015065817A1 (en) 2013-10-30 2015-05-07 Merck Sharp & Dohme Corp. Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
US9242965B2 (en) 2013-12-31 2016-01-26 Boehringer Ingelheim International Gmbh Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
CN103948932B (zh) * 2014-04-17 2016-03-16 海南日中天制药有限公司 一种头孢克肟组合物及其制备方法
EP3031450A1 (en) 2014-12-12 2016-06-15 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten capsule compositions
RU2018144043A (ru) 2016-05-13 2020-06-15 Аэромикс, Инк. Кристаллы
CN106397454B (zh) * 2016-08-30 2018-08-24 山东罗欣药业集团股份有限公司 一种抗感染药物头孢布烯晶型化合物及其组合物
CN106397455B (zh) * 2016-08-30 2018-08-31 山东罗欣药业集团恒欣药业有限公司 一种抗感染药物头孢布烯晶体化合物及其组合物
CN106397457A (zh) * 2016-09-21 2017-02-15 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢布烯晶体化合物
CN106432270A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
CN106432271A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢布烯晶体化合物
CN106432272A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
WO2023278945A1 (en) * 2021-07-01 2023-01-05 Qpex Biopharma, Inc. Crystalline forms of ceftibuten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
JPS5726692A (en) * 1980-07-22 1982-02-12 Fujisawa Pharmaceut Co Ltd Preparation of stable crystal of salt of ceftizoxime
DE3037997A1 (de) * 1980-10-08 1982-05-13 Bayer Ag (beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins
AU580855B2 (en) * 1985-03-29 1989-02-02 Shionogi & Co., Ltd. Alkeneamidocephalosporin esters

Also Published As

Publication number Publication date
DK161080C (da) 1991-11-11
HUT44257A (en) 1988-02-29
DK336487D0 (da) 1987-06-30
IL83059A (en) 1992-03-29
AT392472B (de) 1991-04-10
PL159180B1 (pl) 1992-11-30
US4933443A (en) 1990-06-12
RU1829932C (ru) 1993-07-23
CN87105009A (zh) 1988-03-23
ES2008759A6 (es) 1989-08-01
NL193136C (nl) 1998-12-04
HK47893A (en) 1993-05-27
FR2601014B1 (fr) 1990-09-14
AU594167B2 (en) 1990-03-01
CA1283405C (en) 1991-04-23
NO170889B (no) 1992-09-14
NO872729D0 (no) 1987-06-30
FR2601014A1 (fr) 1988-01-08
IE871738L (en) 1988-01-02
CH672788A5 (no) 1989-12-29
US4812561A (en) 1989-03-14
DK161080B (da) 1991-05-27
ATA165887A (de) 1990-09-15
FI872903A (fi) 1988-01-03
SE8702705D0 (sv) 1987-06-30
IL83059A0 (en) 1987-12-31
IE59613B1 (en) 1994-03-09
NO170889C (no) 1992-12-23
PL266567A1 (en) 1988-07-21
GR871014B (en) 1987-11-02
AU7504087A (en) 1988-01-07
SE8702705L (sv) 1988-01-03
AR243893A1 (es) 1993-09-30
HU200777B (en) 1990-08-28
NL193136B (nl) 1998-08-03
DK336487A (da) 1988-01-03
SE466257B (sv) 1992-01-20
GB2192183B (en) 1990-05-16
FI89052B (fi) 1993-04-30
IT8767566A0 (it) 1987-07-01
IT1211469B (it) 1989-11-03
GB2192183A (en) 1988-01-06
KR880001670A (ko) 1988-04-26
FI89052C (fi) 1993-08-10
KR950005302B1 (ko) 1995-05-23
DE3721913A1 (de) 1988-01-07
GB8715064D0 (en) 1987-08-05
ES2004952A6 (es) 1989-02-16
NZ220764A (en) 1989-09-27
FI872903A0 (fi) 1987-07-01
CN1015106B (zh) 1991-12-18
NL8701507A (nl) 1988-02-01
BE1001691A4 (fr) 1990-02-13

Similar Documents

Publication Publication Date Title
NO872729L (no) Cefalosporinhydrat og fremgangsmŸte for dets fremstilling.
NO882356D0 (no) Naeringsmiddel og fremgangsmaate for dets fremstilling.
NO882286D0 (no) Krystallinsk scandiumoksydpulver og fremgangsmaate for dets fremstilling.
NO884135L (no) Vannopploeselig cellulosederivat, fremgangsmaate for dets fremstilling og anvendelse derav.
DK664887A (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
NO873402D0 (no) Dyreforprodukt og fremgangsmaate for dets fremstilling.
NO880434L (no) Bedoevelsesmiddel og fremgangsmaate for bruk derav.
DK84588A (da) Phenylguanidin- og tetrahydropyrimidinholdigt anthelmikum, dets fremstilling og anvendelse
DK185187D0 (da) Lokkemad til snegle, dets fremstilling og anvendelse
NO884416D0 (no) Krystallinsk beta-laktamhydrat og fremgangsmaate for fremstilling derav.
TR23145A (tr) Diflufenican kullanan herbisidal usul
NO175373C (no) Heteropolysakkarid, fremgangsmåte for dets fremstilling og anvendelse
NO880186D0 (no) Tetrapeptidinhibitor samt fremgangsmaate for dets fremstilling og anvendelse derav.
DK50387D0 (da) Rekombinant-humant interleukin-2-praeparat og frem-gangsmaade til dets fremstilling
DK525687A (da) Enzymholdigt praeparat, dets fremstilling og anvendelse
NO870210L (no) Fremgangsmaate og anordning for avskinning.
DK296687A (da) N-1h-tetrazol-5-yl-2-thiophen-carboxamider, n-1h-tetrazol-5-yl-2-pyrrol-carboxamider og n-1h-tetrazol-5-yl-2-furan-carboxamider
NO842155L (no) Meta- og para-isopropenyl-alfa,alfa-dimetylbenzylamin, og fremgangsmaate for fremstilling derav
DK285182A (da) Nematodicidt praeparat, dets fremstilling og anvendelse
DK125087D0 (da) Efomycin g., dets fremstilling og anvendelse
DK144084A (da) Makrolid, dets fremstilling og anvendelse
NO885088D0 (no) Omslagsmateriale, fremgangsmŸte for dets fremstilling og fremgangsmŸte til bruk av materialet.
NO870299D0 (no) Liposom/antrakinon-legemiddelpreparat og fremgangsmaate for dets fremstilling.
IT8720970A0 (it) Procedimento per preparare carnitossi-carnitina e acetilcarnitossi-carnitina.
NO874922L (no) Flerfargebÿnd, og fremgangsmÿte for dets fremstilling.

Legal Events

Date Code Title Description
MK1K Patent expired